BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/21/2017 7:10:38 AM | Browse: 949 | Download: 1848
 |
Received |
|
2017-03-29 10:34 |
|
Peer-Review Started |
|
2017-04-01 16:14 |
|
To Make the First Decision |
|
2017-06-05 00:28 |
|
Return for Revision |
|
2017-06-11 10:14 |
|
Revised |
|
2017-07-06 06:54 |
|
Second Decision |
|
2017-08-07 05:38 |
|
Accepted by Journal Editor-in-Chief |
|
2017-08-09 08:12 |
|
Accepted by Executive Editor-in-Chief |
|
2017-08-15 15:22 |
|
Articles in Press |
|
2017-08-15 15:22 |
|
Publication Fee Transferred |
|
2017-09-19 09:38 |
 |
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-10-12 01:36 |
|
Publish the Manuscript Online |
|
2017-10-21 07:10 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Michele Maria Luchetti, Devis Benfaremo, Francesco Ciccia, Laura Bolognini, Monia Ciferri, Alessia Farinelli, Matteo Rossini, Piergiorgio Mosca, Giovanni Triolo and Armando Gabrielli |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Michele Maria Luchetti, MD, Dipartimento Scienze Cliniche e Molecolari, Clinica Medica, Università Politecnica delle Marche, Ancona 60126, Italy. m.luchetti@univpm.it |
| Key Words |
Clinimetric assessment; Patient reported outcomes; Inflammatory bowel diseases; Enteropathic spondyloarthritis; tumor necrosis factor-inhibitors; Multidisciplinary evaluation |
| Core Tip |
Enteropathic spondyloarthritis (ES) is characterized by articular inflammation in patients with inflammatory bowel diseases, such as Crohn’s disease or ulcerative colitis. Correct management, especially covering both of the two clinical manifestations (gastro-rheumatologic), remains a challenge. In this study, we demonstrated that the integrated gastroenterological and rheumatologic evaluation of ES patients achieved the best therapeutic approach. In particular, we demonstrated that in a real-life cohort of ES patients, the tumor necrosis factor-inhibitor, adalimumab, led to fast and sustained improvement of articular and gastrointestinal inflammation, with a consequent improvement in the global and gastrointestinal quality of life. |
| Publish Date |
2017-10-21 07:10 |
| Citation |
Luchetti MM, Benfaremo D, Ciccia F, Bolognini L, Ciferri M, Farinelli A, Rossini M, Mosca P, Triolo G, Gabrielli A. Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study. World J Gastroenterol 2017; 23(39): 7139-7149 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i39/7139.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i39.7139 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
